Assetmark »

Phio Pharmaceuticals Corp shares owned by Assetmark

Quarter-by-quarter ownership of Phio Pharmaceuticals Corp (PHIO) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Phio Pharmaceuticals Corp

Tip: Access up to 7 years of quarterly data

All positions including Phio Pharmaceuticals Corp held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phio Pharmaceuticals Corp by Assetmark

Quarter filed Position value Share count Share price at filing
2025-09-30 $272 110 2.48
2025-06-30 $258 110 2.35
2025-03-31 $143 110 1.30

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Proshares Tr Pshs Ult S&p 500 (SSO)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Tr Iboxx Hi Yd Etf (HYG)

View all positions for Assetmark

Top funds holding Phio Pharmaceuticals Corp

Vanguard Group
Geode Capital Management
Cetera Investment Advisers
Morgan Stanley
SBI Securities
Bnp Paribas Arbitrage, Snc
Tower Research Capital
Assetmark
UBS Group
Activest Wealth Management

View all funds holding Phio Pharmaceuticals Corp